Trending Upwards

Trending Upwards was paid $3.58M by Medicaid between Feb 2019 and Dec 2024, across 18 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 44% of everything it billed.

Compared with peers

Next to other Addiction (Substance Use Disorder) Counselor providers in Kentucky

Rank by total paid#18 of 112

Median peer was paid$240K

This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	7,698	$409K
2020	12,046	$733K
2021	17,078	$1.06M
2022	10,579	$648K
2023	7,101	$413K
2024incomplete	7,649	$311K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	44%	13,013	5,123	$1.57M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	15%	14,652	5,834	$525K
T2023	Targeted case management; per month	14%	1,878	1,420	$494K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	9.4%	11,227	4,311	$335K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.2%	8,851	5,529	$293K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.0%	1,001	736	$71K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	1.9%	1,154	701	$67K
T1007	Alcohol and/or substance abuse services, treatment plan development and/or modification	1.6%	1,117	1,052	$59K
H0038	Self-help/peer services, per 15 minutes	1.6%	2,686	926	$58K
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	<1%	752	424	$29K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,594	1,327	$16K
81025		<1%	2,523	2,102	$13K

6 more codes

90837	Psychotherapy session, about an hour	<1%	199	$13K
99203	Doctor's office visit, new patient (routine)	<1%	277	$12K
80305		<1%	837	$8K
90791	Psychiatric diagnostic evaluation	<1%	76	$6K
H0001	Alcohol and/or drug assessment	<1%	94	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	220	$4K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNOBLE, DEBORAH (CO-OWNER)